Invus Public Equities Advisors
Latest statistics and disclosures from Invus Public Equities Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are GS, Acorda Therapeutics, Auxilium Pharmaceuticals, Google, MET, and represent 33.60% of Invus Public Equities Advisors's stock portfolio.
- Added to shares of these 10 stocks: GS (+$57M), Acorda Therapeutics (+$55M), Auxilium Pharmaceuticals (+$50M), Google (+$41M), MET (+$35M), JPM (+$33M), Express Scripts (+$30M), WFC (+$28M), CSCO (+$23M), PFE (+$21M).
- Started 51 new stock positions in Bg Medicine, V, CSCO, Beazer Homes USA, Furiex Pharmaceuticals, Citigroup Inc unit, NG, F, EWZ, Acorda Therapeutics.
- Invus Public Equities Advisors was a net buyer of stock by $706M.
- Invus Public Equities Advisors has $706M in assets under management (AUM).
- Central Index Key (CIK): 0001340096
Portfolio Holdings for Invus Public Equities Advisors
Invus Public Equities Advisors holds 51 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Goldman Sachs (GS) | 8.0 | $57M | NEW | 425k | 133.09 |
|
| Acorda Therapeutics | 7.8 | $55M | NEW | 1.7M | 32.31 |
|
| Auxilium Pharmaceuticals | 7.1 | $50M | NEW | 2.5M | 19.60 |
|
| 5.7 | $41M | NEW | 80k | 506.38 |
|
|
| MetLife (MET) | 5.0 | $35M | NEW | 800k | 43.87 |
|
| JPMorgan Chase & Co. (JPM) | 4.6 | $33M | NEW | 800k | 40.94 |
|
| Express Scripts | 4.2 | $30M | NEW | 550k | 53.98 |
|
| Wells Fargo & Company (WFC) | 4.0 | $28M | NEW | 1.0M | 28.06 |
|
| Cisco Systems (CSCO) | 3.3 | $23M | NEW | 1.5M | 15.61 |
|
| Pfizer (PFE) | 2.9 | $21M | NEW | 1.0M | 20.60 |
|
| Nektar Therapeutics (NKTR) | 2.8 | $20M | NEW | 2.8M | 7.27 |
|
| Qualcomm (QCOM) | 2.8 | $20M | NEW | 350k | 56.79 |
|
| Martin Marietta Materials (MLM) | 2.6 | $18M | NEW | 230k | 79.97 |
|
| AVANIR Pharmaceuticals | 2.5 | $17M | NEW | 5.2M | 3.36 |
|
| Visa (V) | 2.4 | $17M | NEW | 200k | 84.26 |
|
| Citigroup (C) | 2.4 | $17M | NEW | 400k | 41.64 |
|
| Hca Holdings (HCA) | 2.3 | $17M | NEW | 500k | 33.00 |
|
| BRF Brasil Foods SA (BRFS) | 2.1 | $15M | NEW | 850k | 17.33 |
|
| Ford Motor Company (F) | 1.9 | $14M | NEW | 1.0M | 13.79 |
|
| Bank of America Corporation (BAC) | 1.9 | $13M | NEW | 1.2M | 10.96 |
|
| Onyx Pharmaceuticals | 1.8 | $12M | NEW | 350k | 35.30 |
|
| General Motors Company (GM) | 1.7 | $12M | NEW | 400k | 30.36 |
|
| Mindray Medical International | 1.7 | $12M | NEW | 425k | 28.05 |
|
| Furiex Pharmaceuticals | 1.6 | $11M | NEW | 625k | 17.79 |
|
| Arch Coal | 1.5 | $11M | NEW | 400k | 26.66 |
|
| Crown Castle International | 1.4 | $10M | NEW | 250k | 40.79 |
|
| American International (AIG) | 1.2 | $8.8M | NEW | 300k | 29.32 |
|
| Schlumberger (SLB) | 1.2 | $8.6M | NEW | 100k | 86.40 |
|
| Meritor | 1.1 | $8.0M | NEW | 500k | 16.04 |
|
| MasterCard Incorporated (MA) | 1.1 | $7.5M | NEW | 25k | 301.36 |
|
| iShares MSCI Brazil Index (EWZ) | 1.0 | $7.3M | NEW | 100k | 73.35 |
|
| Lexicon Pharmaceuticals | 1.0 | $6.8M | NEW | 3.9M | 1.76 |
|
| SMART Technologies | 0.9 | $6.3M | NEW | 1.1M | 5.70 |
|
| Eaton Corporation | 0.7 | $5.1M | NEW | 100k | 51.45 |
|
| Citigroup Inc unit | 0.7 | $5.2M | NEW | 43k | 120.14 |
|
| Morgan Stanley (MS) | 0.7 | $4.6M | NEW | 200k | 23.01 |
|
| Tata Motors | 0.6 | $4.5M | NEW | 200k | 22.51 |
|
| Motorola Mobility Holdings | 0.6 | $4.4M | NEW | 200k | 22.04 |
|
| Lamar Advertising Company | 0.5 | $3.8M | NEW | 138k | 27.37 |
|
| Affymetrix | 0.4 | $2.6M | NEW | 325k | 7.93 |
|
| Biodel | 0.3 | $2.2M | NEW | 1.2M | 1.87 |
|
| McKesson Corporation (MCK) | 0.3 | $2.1M | NEW | 25k | 83.64 |
|
| Pmi Group | 0.3 | $2.1M | NEW | 2.0M | 1.07 |
|
| Simcere Pharmaceutical | 0.3 | $2.0M | NEW | 200k | 9.77 |
|
| Beazer Homes USA | 0.2 | $1.7M | NEW | 500k | 3.39 |
|
| Micromet | 0.2 | $1.4M | NEW | 250k | 5.74 |
|
| Bg Medicine | 0.2 | $1.1M | NEW | 143k | 7.96 |
|
| Novagold Resources Inc Cad (NG) | 0.1 | $920k | NEW | 100k | 9.20 |
|
| Pacific Biosciences of California (PACB) | 0.1 | $738k | NEW | 63k | 11.70 |
|
| shares Agenus | 0.1 | $390k | NEW | 500k | 0.78 |
|
| Microvision Inc Del *w exp 07/23/201 | 0.0 | $76k | NEW | 361k | 0.21 |
|
Past Filings by Invus Public Equities Advisors
SEC 13F filings are viewable for Invus Public Equities Advisors going back to 2011
- Invus Public Equities Advisors 2011 Q2 filed Aug. 15, 2011
- Invus Public Equities Advisors 2011 Q1 filed April 27, 2011